Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bicycle Therapeutics (BCYC) Net Margin: 2018-2025

Historic Net Margin for Bicycle Therapeutics (BCYC) over the last 8 years, with Sep 2025 value amounting to -503.66%.

  • Bicycle Therapeutics' Net Margin rose 139477.00% to -503.66% in Q3 2025 from the same period last year, while for Sep 2025 it was 4,369.94%, marking a year-over-year increase of 709936.00%. This contributed to the annual value of -14,085.92% for FY2024, which is 1067716.00% down from last year.
  • Per Bicycle Therapeutics' latest filing, its Net Margin stood at -503.66% for Q3 2025, which was up 81.37% from -2,703.84% recorded in Q2 2025.
  • Bicycle Therapeutics' Net Margin's 5-year high stood at 300.39% during Q4 2023, with a 5-year trough of -2,703.84% in Q2 2025.
  • In the last 3 years, Bicycle Therapeutics' Net Margin had a median value of -503.66% in 2025 and averaged -729.86%.
  • Its Net Margin has fluctuated over the past 5 years, first spiked by 189,774bps in 2022, then plummeted by 227,854bps in 2025.
  • Bicycle Therapeutics' Net Margin (Quarterly) stood at -2,254.62% in 2021, then skyrocketed by 189,774bps to -356.88% in 2022, then skyrocketed by 65,727bps to 300.39% in 2023, then crashed by 12,963bps to 170.76% in 2024, then skyrocketed by 139,477bps to -503.66% in 2025.
  • Its last three reported values are -503.66% in Q3 2025, -2,703.84% for Q2 2025, and -608.94% during Q1 2025.